Robert Vardanyan

Mr. Robert Vardanyan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2021 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
Arian Arjomandi RadArian Arjomandi Rad
Arian Arjomandi Rad
RVRobert Vardanyan
Robert Vardanyan
STSanthosh G Thavarajasingam
Santhosh G Thavarajasingam
AZAlina Zubarevich
Alina Zubarevich
Jef Van den EyndeJef Van den Eynde
Jef Van den Eynde
AWAlexander Weymann
Alexander Weymann
: OBJECTIVES: Extended reality (XR), encompassing both virtual reality (VR) and augmented reality, allows the user to interact with a computer-generated environment based on reality. In essence, the immersive nature of VR and augmented reality technology has been warmly welcomed in all aspects of medicine, gradually becoming increasingly feasible to incorporate into everyday practice. In recent years, XR has become increasingly adopted in thoracic surgery, although the extent of its applications is unclear. Here, we aim to review the current applications of XR in thoracic surgery. METHODS: A systematic database search was conducted of original articles that explored the use of VR and/or augmented reality in thoracic surgery in EMBASE, MEDLINE, Cochrane database and Google Scholar, from inception to December 2020. RESULTS: Our search yielded 1494 citations, of which 21 studies published from 2007 to 2019 were included in this review. Three main areas were identified: (i) the application of XR in thoracic surgery training; (ii) preoperative planning of thoracic procedures; and (iii) intraoperative assistance. Overall, XR could produce progression along the learning curve, enabling trainees to reach acceptable standards before performing in the operating theatre. Preoperatively, through the generation of 3D-renderings of the thoracic cavity and lung anatomy, VR increases procedural accuracy and surgical confidence through familiarization of the patient’s anatomy. XR-assisted surgery may have therapeutic use particularly for complex cases, where conventional methods would yield inadequate outcomes due to inferior accuracy. CONCLUSION: XR represents a salient step towards improving thoracic surgical training, as well as enhancing preoperative planning and intraoperative guidance.

8 April 2022 in British Journal Of Neurosurgery
Verified
Journal Article
Open access
STSanthosh G. Thavarajasingam
Santhosh G. Thavarajasingam
RVRobert Vardanyan
Robert Vardanyan
Arian Arjomandi RadArian Arjomandi Rad
Arian Arjomandi Rad
ATAhkash Thavarajasingam
Ahkash Thavarajasingam
AKArtur Khachikyan
Artur Khachikyan
PVPeter Vajkoczy
Peter Vajkoczy
Augmented reality (AR) has become a promising tool in neurosurgery. It can minimise the anatomical challenges faced by conventional endoscopic or microscopic transsphenoidal reoperations and can as...

20 February 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Arian Arjomandi RadArian Arjomandi Rad
Arian Arjomandi Rad
AZAlina Zubarevich
Alina Zubarevich
Anja OsswaldAnja Osswald
Anja Osswald
RVRobert Vardanyan
Robert Vardanyan
Dimitrios E. MagouliotisDimitrios E. Magouliotis
Dimitrios E. Magouliotis
AWAlexander Weymann
Alexander Weymann
Infective endocarditis (IE) is a severe cardiac complication with high mortality rates, especially when surgical intervention is delayed or absent. This review addresses the expanding role of surgery in managing IE, focusing on the variation in surgical treatment rates, the impact of patient demographics, and the effectiveness of different surgical approaches. Despite varying global data, a notable increase in surgical interventions for IE is evident, with over 50% of patients undergoing surgery in tertiary centres. This review synthesizes information from focused literature searches up to July 2023, covering preoperative to postoperative considerations and surgical strategies for IE. Key preoperative concerns include accurate diagnosis, appropriate antimicrobial treatment, and the timing of surgery, which is particularly crucial for patients with heart failure or at risk of embolism. Surgical approaches vary based on valve involvement, with mitral valve repair showing promising outcomes compared to replacement. Aortic valve surgery, traditionally favouring replacement, now includes repair as a viable option. Emerging techniques such as sutureless valves and aortic homografts are explored, highlighting their potential advantages in specific IE cases. The review also delves into high-risk groups like intravenous drug users and the elderly, emphasizing the need for tailored surgical strategies. With an increasing number of patients presenting with prosthetic valve endocarditis and device-related IE, the review underscores the importance of comprehensive management strategies encompassing surgical and medical interventions. Overall, this review provides a comprehensive overview of current evidence in the surgical management of IE, highlighting the necessity of a multidisciplinary approach and ongoing research to optimize patient outcomes.

21 April 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
Arian Arjomandi RadArian Arjomandi Rad
Arian Arjomandi Rad
VNVinci Naruka
Vinci Naruka
RVRobert Vardanyan
Robert Vardanyan
AVAlessandro Viviano
Alessandro Viviano
MSMohammad Yousuf Salmasi
Mohammad Yousuf Salmasi
Thanos AthanasiouThanos Athanasiou
Thanos Athanasiou
Mitral and tricuspid ring annuloplasty dehiscence with consequent recurrent valve regurgitation is a rare but challenging procedural failure. The incidence and predisposing risk factors for annuloplasty ring dehiscence include technical and pathological ones. A systematic database search with pooled analysis was conducted of original articles that only included dehiscence rate of mitral and tricuspid ring in EMBASE, MEDLINE, Cochrane database and Google Scholar, from inception to November 2020. The outcomes included were dehiscence rate in mitral and tricuspid, type of ring implanted, dehiscence rate by pathology and by ring size and shape. Our search yielded 821 relevant studies. Thirty-three studies met the inclusion criteria with a total of 10 340 patients (6543 mitral, 1414 tricuspid) of which 87 (mitral) and 30 (tricuspid) had dehiscence. Overall, dehiscence rate was 1.43%, diagnosed at a median of 4.5 ± 1.0 months postoperatively. A significant difference in mitral dehiscence rate was found by ring type (semi-rigid 1.86%, rigid 2.32%; flexible 0.43%; P < 0.001). There was no significant difference in rate of dehiscence by ring size (P = 0.067) and shape in mitral (P = 0.281) but there was higher dehiscence rate in ischaemic compared to non-ischaemic mitral regurgitation (3.91% vs 1.63%; P = 0.022). Among tricuspid studies, 9 of 10 studies did not report any dehiscence. Although rigid, semi-rigid and flexible annuloplasty rings provide acceptable valve repair outcomes, mitral annuloplasty ring dehiscence is clinically more common among rigid rings. Understanding the multifactorial nature of ring dehiscence will help in identifying the patients at high risk and improve their clinical outcomes.

21 October 2020 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
PDF file
AZAlina Zubarevich
Alina Zubarevich
KZKonstantin Zhigalov
Konstantin Zhigalov
AOAnja Osswald
Anja Osswald
Arian Arjomandi RadArian Arjomandi Rad
Arian Arjomandi Rad
RVRobert Vardanyan
Robert Vardanyan
AWAlexander Weymann
Alexander Weymann
In rare cases of extensive aortic root or mitral valve infective endocarditis (IE), severe calcification of the aortic and mitral valves, or double‐valve procedures in patients with small aortic and mitral annuli, surgical reconstruction of the intervalvular fibrous body (IVFB) is required. A high mortality is generally associated with this procedure, and it is frequently avoided by surgeons due to a lack of experience. It is crucial to radically resect all tissues that are severely affected by IE to prevent recurrence in the patient. Our experience with the Commando procedure in patients with extensive double‐valve IE involving the IVFB is presented in this article.

2 April 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
PDF file
STSaeed Torabi
Saeed Torabi
Arian Arjomandi RadArian Arjomandi Rad
Arian Arjomandi Rad
RVRobert Vardanyan
Robert Vardanyan
ALAleksandra T. Lopuszko
Aleksandra T. Lopuszko
Jef Van den EyndeJef Van den Eynde
Jef Van den Eynde
AWAlexander Weymann
Alexander Weymann
Introduction Primary cardiac sarcomas (PCSs) are an extremely rare and aggressive type of malignancies that have been described only by a limited number of observational studies. This study aimed to evaluate the currently existing evidence comparing surgical to multimodality treatment of PCS. Methods We systematically reviewed Embase, MEDLINE, Cochrane Database, and Google Scholar, from inception to December 2020, for original articles about surgical and multimodality treatment of PCS. The outcomes included were mortality at various time points, resection margin status, and mean estimated survival. The pooled treatment effects were calculated using a random‐effects model. Results Ten studies including a total of 1570 patients met our inclusion criteria. Surgery was associated with significantly lower mortality when compared to conservative treatment at 1, 2, and 3 years, whereas no significant difference was found at 5 years. Furthermore, multimodality treatment showed significantly lower mortality at 1 year when compared to surgery alone, but not at 2 and 5 years. We found no difference in mortality between angiosarcomas and other PCS subtypes. Conclusion Overall, surgery was found to provide a significant mortality advantage to PCS patients up to 3 years following treatment. Multimodality treatment might be of additional benefit, although only within the first year. Prospective randomized studies are needed to further explore these differences in the treatment of PCS.